The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1.
Open accessAbstract
The involvement of Sp1 in regulating cell proliferation in myeloid leukemia cells was determined by measuring the levels and DNA binding activity of Sp1 in TF-1 cells, a human erythroleukemia cell line dependent on granulocyte/macrophage colony-stimulating factor (GM-CSF) for viability and cell growth. DNA binding of Sp1 to a specific double-stranded oligodeoxynucleotide was increased markedly in a dose-dependent manner in proliferating cells in response to GM-CSF compared with growth-arrested or apoptotic cells. Competition experiments and mobility shift interference assays with antibodies against Sp1 as well as wild-type or mutant p53 indicated that GM-CSF-inducible DNA-binding complexes contained both Sp1 and p53 and that these heterocomplexes bound to both p53- and Sp1-binding sequences with high affinity. Immunoprecipitation of nuclear extracts with a p53 antibody indicated that Sp1 was associated as a heterocomplex with p53. Formation of this complex was dependent on the level of p53 since p53 was more abundant in proliferating cells and decreased upon induction of growth arrest and apoptosis by withdrawal of GM-CSF while Sp1 levels remained unchanged. These results suggest that the association of Sp1 with p53 may represent a novel mechanism of growth regulation in cytokine-dependent leukemia cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1993, p53 was first reported to bind to coactivators, including the TATA-box binding protein,73, 74 the CCAAT-box binding factor (NF-Y)75 and specificity protein 1 (Sp1) that binds to GC-boxes,76 and to interfere with their transactivator function.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [76]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,499
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,046
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,292
Fos and jun: The AP-1 connection
Curran, T., & Franza, B. R. (1988) · Cell · doi:10.1016/0092-8674(88)90024-4 · Cited by 1,595
Regulation of Inducible and Tissue-Specific Gene Expression
Maniatis, T., Goodbourn, S., & Fischer, J. A. (1987) · Science · doi:10.1126/science.3296191 · Cited by 1,553
Dynan, W. S., & Tjian, R. (1983) · Cell · doi:10.1016/0092-8674(83)90210-6 · Cited by 1,445
Imagawa, M. (1987) · Cell · doi:10.1016/0092-8674(87)90152-8 · Cited by 1,384
Research works printed but not linked: 7
- Borellini, 1990, Mol. Cell. Biol., 10, 5541
- Kim, 1992, Mol. Cell. Biol., 12, 2455
- Koury, 1992, Exp. Hematol., 20, 391
- Mercer, 1984, Mol. Cell. Biol., 4, 276
- Nakamura, 1991, Cell Growth & Differ., 2, 267
- Shabo, 1990, Leukemia, 4, 797
- Zhang, 1992, Oncogene, 7, 1039
Cited by
Sorted by citations
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,048
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen‐Schaub, L. B., Zhang, W. K., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A., Zhang, W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 740
Mirza, A., McGuirk, M., Hockenberry, T., Wu, Q. J., Ashar, H. R., Black, S., Wen, S. F., Wang, L., Kirschmeier, P. T., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 533
p53 in growth control and neoplasia
Gottlieb, T. M., & Oren, M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00019-c · Cited by 483
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. H. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Karumanchi, S. A., & Sukhatme, V. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5629 · Cited by 337
Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.
Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T. T., Yao, J. C., Ajani, J. A., & Xie, K. (2003) · PubMed · Cited by 334
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 291
Xu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., & Pisa, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203890 · Cited by 257
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929 · Cited by 237
Zhang, L., Yu, D., Hu, M., Xiong, S., Lang, A., Ellis, L. M., & Pollock, R. E. (2000) · PubMed · Cited by 230
Egger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2669-2679.2003 · Cited by 214
Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase
Rohlff, C., Ahmad, S., Borellini, F., Lei, J., & Glazer, R. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21137 · Cited by 206
Self-citationYao, J. C., Wang, L., Wei, D., Gong, W., Hassan, M. M., Wu, T., Mansfield, P. F., Ajani, J. A., & Xie, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0628 · Cited by 198
Activation of the cryptic DNA binding function of mutant forms of p53
Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3167 · Cited by 190
Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Muñoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 185
Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., & Schuetz, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11037 · Cited by 161
DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 168
Koutsodontis, G., Tentes, I. K., Papakosta, P., Moustakas, A., & Kardassis, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104130200 · Cited by 159
Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 157
Liu, Z., & Simpson, E. R. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9890 · Cited by 156
Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor
Wang, Q., Zambetti, G. P., & Suttle, D. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.389 · Cited by 152
Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 149
Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression
Scian, M. J., Stagliano, K. E., Anderson, M. A. E., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10097-10110.2005 · Cited by 152
p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression
Sun, Y., Sun, Y., Wenger, L., Rutter, J. L., Brinckerhoff, C., & Cheung, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11535 · Cited by 145
Nuclear Receptor-Mediated Transactivation Through Interaction with Sp Proteins
Safe, S. H., & Kim, K. (2004) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)77001-4 · Cited by 143
Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells
Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., & Nicot, C. (2004) · Blood · doi:10.1182/blood-2003-12-4251 · Cited by 129
Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 118
Modulation of Gene Expression by Tumor-Derived p53 Mutants
Scian, M. J., Stagliano, K. E., Ellis, M. A., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1568 · Cited by 117
The Cyclin A1-CDK2 Complex Regulates DNA Double-Strand Break Repair
Müller‐Tidow, C., Ji, P., Diederichs, S., Potratz, J. C., Bäumer, N., Köhler, G., Cauvet, T., Choudary, C., van der Meer, T., Chan, W. Y. I., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8917-8928.2004 · Cited by 115
Zaky, A., Busso, C., Izumi, T., Chattopadhyay, R., Bassiouny, A., Mitra, S., & Bhakat, K. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1173 · Cited by 111
p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism
Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929-1938.1994 · Cited by 104
Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 101
Gualberto, A., & Baldwin, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19680 · Cited by 101
The (patho)physiological functions of the MRP family
Renes, J., de Vries, E. G. E., Jansen, P. L. M., & Müller, M. M. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0156 · Cited by 100
Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene
Cohen, H. T., Bossone, S., Zhu, G., McDonald, G. A., & Sukhatme, V. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2901 · Cited by 100
Yan, C., Wang, H., & Boyd, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112069200 · Cited by 93
Sun, Y., Cheung, J. M., Martel‐Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., & Cheung, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11327 · Cited by 97
Bocangel, D., Sengupta, S., MITRA, S. P., & Bhakat, K. K. (2009) · PubMed · Cited by 94
Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53
Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., & Furuichi, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6191 · Cited by 91
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication
Duan, L., Ozaki, I., Oakes, J. W., Taylor, J. P., Khalili, K., & Pomerantz, R. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4302-4313.1994 · Cited by 92
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 89
Yang, J. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.6.1117 · Cited by 86
Thornborrow, E. C., & Manfredi, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011643200 · Cited by 85
Regulation of Sp1 by cell cycle related proteins
Tapias, A., Ciudad, C. J., Roninson, I. B., & Noé, V. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6671 · Cited by 82
A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening
Gunther, M., Laithier, M., & Brison, O. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007177623283 · Cited by 81
Role of Sp1 in cAMP-dependent Transcriptional Regulation of the Bovine CYP11A Gene
Ahlgren, R., Suske, G., Waterman, M. R., & Lund, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19422 · Cited by 78
Pietrzak, M., & Puzianowska‐Kuźnicka, M. (2008) · Biological Chemistry · doi:10.1515/bc.2008.039 · Cited by 77
Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T., & Puisieux, A. (2002) · Gene · doi:10.1016/s0378-1119(01)00825-3 · Cited by 73
Liu, Z., & R. Simpson, E. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00036-2 · Cited by 71
Dittmer, J., Gégonne, A., Gitlin, S. D., Ghysdael, J., & Brady, J. N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31821-5 · Cited by 71
D’Souza, S., Xin, H., Walter, S., & Choubey, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007155200 · Cited by 72
Gac, G. L., Estève, P., Férec, C., & Pradhan, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603724200 · Cited by 70
P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3
Zerrouqi, A., Pyrzynska, B., Febbraio, M., Brat, D. J., & Van Meir, E. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38596 · Cited by 70
Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNA
Chicas, A., Molina, P. E., & Bargonetti, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3965 · Cited by 69
Regulation of multidrug resistance through the cAMP and EGF signalling pathways
Rohlff, C., & Glazer, R. I. (1995) · Cellular Signalling · doi:10.1016/0898-6568(95)00018-k · Cited by 69
Self-citationGoldsmith, M. E., Gudas, J. M., Schneider, E., & Cowan, K. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1894 · Cited by 67
Li, B., & Lee, M. Y. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101167200 · Cited by 65
p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression
Nishi, H., Senoo, M., Nishi, K., Murphy, B., Rikiyama, T., Matsumura, Y., Habu, S., & Johnson, A. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101241200 · Cited by 65
Infrequent mutations of the p53 gene in pulmonary carcinoid tumors.
Lohmann, D. R., FESSELER, B., Pütz, B., Reich, U., Böhm, J., Präuer, H. W., Wünsch, P. H., & Höfler, H. (1993) · PubMed · Cited by 65
Response of heat shock element within the human HSP70 promoter to mutated p53 genes.
Tsutsumi‐Ishii, Y., Tadokoro, K., Hanaoka, F., & Tsuchida, N. (1995) · PubMed · Cited by 64
Shen, L., Dean, N. M., & Glazer, R. I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12039-1 · Cited by 64
Self-citationLead Exposure in Pheochromocytoma (PC12) Cells Alters Neural Differentiation and Sp1 DNA-Binding
Crumpton, T. L., Atkins, D. S., Zawia, N. H., & Barone, S. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(00)00008-5 · Cited by 62
Specificity Protein 1 (Sp1) Maintains Basal Epithelial Expression of the miR-200 Family
Kolesnikoff, N., Attema, J. L., Roslan, S., Bert, A. G., Schwarz, Q., Gregory, P. A., & Goodall, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529172 · Cited by 60
Persengiev, S. P., Raval, P., Rabinovitch, S., Millette, C. F., & Kilpatrick, D. L. (1996) · Endocrinology · doi:10.1210/en.137.2.638 · Cited by 60
Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region
Han, B., Dong, Z., Liu, Y., Chen, Q., Hashimoto, K., & Zhang, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206783 · Cited by 58
p53-Dependent Transcriptional Control of Cellular Prion by Presenilins
Vincent, B., Sunyach, C., Orzechowski, H., George‐Hyslop, P. S., & Checler, F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0789-09.2009 · Cited by 62
Ramaiah, M. J., Naushad, S. M., Ponnusamy, L., Arivazhagan, G., Sakthiprasad, V., & Pal‐Bhadra, M. (2017) · Gene · doi:10.1016/j.gene.2017.10.018 · Cited by 59
Sun, Y., Zeng, X., Wenger, L., Firestein, G. S., & Cheung, H. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20044 · Cited by 57
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
Torgeman, A., Mor‐Vaknin, N., Zelin, E., Ben-Aroya, Z., Löchelt, M., Flügel, R. M., & Aboud, M. (2001) · Virology · doi:10.1006/viro.2000.0779 · Cited by 54
Takada, N., Sanda, T., Okamoto, H., Yang, J., Asamitsu, K., Sarol, L. D. C., Kimura, G., Uranishi, H., Tetsuka, T., & Okamoto, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8019-8030.2002 · Cited by 53
Zhan, M., Yu, D., Liu, J., Hannay, J. A. F., & Pollock, R. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407450200 · Cited by 52
Benoît, V., Hellin, A., Huygen, S., GIELEN, J. E., Bours, V., & Merville, M.-P. (2000) · Oncogene · doi:10.1038/sj.onc.1203831 · Cited by 52
Gueven, N., Keating, K. E., Chen, P., Fukao, T., Khanna, K. K., Watters, D. J., Rodemann, H. P., & Lavin, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006190200 · Cited by 51
Kelavkar, U. P., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4378 · Cited by 49
A Comparison of Apoptosis and Necrosis Induced by Hepatotoxins in HepG2 Cells
O’Brien, T. J., Babcock, G. F., Cornelius, J. R., Dingeldein, M., Talaska, G., Warshawsky, D., & Mitchell, K. R. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8917 · Cited by 49
Wang, F., Wang, W., & Safe, S. H. (1999) · Biochemistry · doi:10.1021/bi982578f · Cited by 49
The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression
van Bodegom, D., Saifudeen, Z. R., Dipp, S., Puri, S., Magenheimer, B. S., Calvet, J. P., & El-Dahr, S. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606510200 · Cited by 46
p53, proto-oncogene and rheumatoid arthritis
Sun, Y., & Cheung, H. S. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.31550 · Cited by 45
Subler, M. A., Martin, D. W., & Deb, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.103-110.1994 · Cited by 45
BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
Nie, E., Jin, X., Wu, W., Yu, T., Zhou, X., Zhi, T., Shi, Z., Zhang, J., Liu, N., & You, Y. (2016) · Scientific Reports · doi:10.1038/srep39743 · Cited by 47
Shen, L., & Glazer, R. I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00045-8 · Cited by 39
Self-citationThe NF-Y/p53 liaison: Well beyond repression
Imbriano, C., Gnesutta, N., & Mantovani, R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.001 · Cited by 39
Cheng, Y.-H., Chang, L. W., & Tsou, T. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0045-1 · Cited by 38
Regulation of p53 mediated transactivation by the β‐subunit of protein kinase CK2
Schuster, N., Prowald, A., Schneider, E., Scheidtmann, K., & Montenarh, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00273-2 · Cited by 37
Gualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3450 · Cited by 37
p53: Its Mutations and Their Impact on Transcription
Vaughan, C. A., Pearsall, I., Yeudall, W. A., Deb, S. P., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_4 · Cited by 37
Dey, A., Atcha, I. A., & Bagchi, S. (1997) · Virology · doi:10.1006/viro.1996.8363 · Cited by 33
E2Fs and the Retinoblastoma Protein Family
Sardet, C., Cam, L. L., Fabbrizio, E., & Vidal, M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_1 · Cited by 33
Tissue-specific p53 expression in the nervous system
Tendler, Y., Weisinger, G., Coleman, R., Diamond, E., Lischinsky, S., Kerner, H., Rotter, V., & Zinder, O. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00202-8 · Cited by 32
Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific Manner
Hudson, J. M., Frade, R., & Bar‐Eli, M. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.759 · Cited by 29
Transcriptional involvement in neurotoxicity
Zawia, N. H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00161-3 · Cited by 28
The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy
Milosavljević, V., Haddad, Y., Rodrigo, M. Á. M., Moulick, A., Polanska, H. H., Hynek, D., Heger, Z., Kopel, P., & Adam, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163983 · Cited by 28
Metadata
- Authors
- Borellini, F., & Glazer, R. I.
- Affiliations
- Georgetown University Medical Center (US)
- ORCID
- Glazer, R.I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1993-04
- Volume
- 268
- Issue
- 11
- Pages
- 7923-7928
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1547769073
- Cited by
- 147
- References
- 48
- Citations by year
- 2025: 1 · 2022: 1 · 2018: 1 · 2017: 2 · 2016: 3 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca054231-03)
- National Cancer Institute (CA54231)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Sp1, p53, heterocomplexes, DNA binding, GM-CSF, erythroleukemia, TF-1 cell line, cell proliferation, growth regulation, apoptosis, growth arrest, transcription factor binding sites
- MeSH terms
- Base Sequence, Cell Division, Cell Nucleus, Chromatin, DNA-Binding Proteins, DNA, Neoplasm, Leukemia, Erythroblastic, Acute, Humans, Microscopy, Electron, Molecular Sequence Data, Oligodeoxyribonucleotides, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Granulocyte-Macrophage Colony-Stimulating Factor, Sp1 Transcription Factor, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review